AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

about

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.

P2860

Q47687378-C1DDD1BA-C697-446F-B22E-3DE1B22B3716

P2860

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

Item

http://www.wikidata.org/entity/Q47563113

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@en

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@nl

type

Item

label

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@en

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@nl

prefLabel

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@en

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@nl

P1476

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

@en

P2093

Fernando J Martinez

http://www.w3.org/2001/XMLSchema#string

Kevin K Brown

http://www.w3.org/2001/XMLSchema#string

Robert J Kaner

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy and safety of sirolimus in lymphangioleiomyomatosis.

Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy

Primary pulmonary sarcoidosis. I. Early signs and symptoms

The Nickerson-Kveim reaction in sarcoidosis

American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias. This joint statement of the American Thoracic Society (ATS), and the European Respiratory Soci

Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis

Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis

A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis

P304

1104-1107

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1164/RCCM.201703-0584ED

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

195

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28459330

http://www.w3.org/2001/XMLSchema#string

P932

5803662

http://www.w3.org/2001/XMLSchema#string

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

about

P2860

P2860

AJRCCM: 100-Year Anniversary. Progress in Interstitial Lung Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P932